Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.

Alzheimers Res Ther · 2021 · PMC8283833 · PMID 34266503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In agreement with our Fine-Gray model findings, short and long rLTL showed a trend of a decreased cause-specific risk of AD among APOE ε4-carriers, when compared with medium rLTL APOE ε4-carriers (Supplementary Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.